These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3793724)

  • 1. Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells.
    McGuire EA; Tollefsen DM
    J Biol Chem; 1987 Jan; 262(1):169-75. PubMed ID: 3793724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II.
    Shirk RA; Church FC; Wagner WD
    Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1138-46. PubMed ID: 8792767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of heparin cofactor II by dermatan sulfate.
    Tollefsen DM; Pestka CA; Monafo WJ
    J Biol Chem; 1983 Jun; 258(11):6713-6. PubMed ID: 6687888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of heparin cofactor II on thrombin-stimulated prostacyclin production by cultured vascular smooth muscle cells.
    Hayashi T; Kaji T; Hayakawa Y; Niiya K; Sakamoto M; Sakuragawa N
    Thromb Res; 1991 Nov; 64(3):321-30. PubMed ID: 1805447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
    Halldórsdóttir AM; Zhang L; Tollefsen DM
    Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
    Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI
    J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
    Blinder MA; Tollefsen DM
    J Biol Chem; 1990 Jan; 265(1):286-91. PubMed ID: 2104620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation.
    Parker KA; Tollefsen DM
    J Biol Chem; 1985 Mar; 260(6):3501-5. PubMed ID: 3838315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells.
    Kaji T; Itoh F; Hayakawa Y; Oguma Y; Sakuragawa N
    Thromb Res; 1989 Oct; 56(1):99-107. PubMed ID: 2512688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
    Sheehan JP; Tollefsen DM; Sadler JE
    J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II.
    Tollefsen DM; Peacock ME; Monafo WJ
    J Biol Chem; 1986 Jul; 261(19):8854-8. PubMed ID: 3755134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of basic residues of the A helix of heparin cofactor II to heparin- or dermatan sulfate-mediated thrombin inhibition.
    Hayakawa Y; Hirashima Y; Kurimoto M; Hayashi N; Hamada H; Kuwayama N; Endo S
    FEBS Lett; 2002 Jul; 522(1-3):147-50. PubMed ID: 12095635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate.
    Blinder MA; Andersson TR; Abildgaard U; Tollefsen DM
    J Biol Chem; 1989 Mar; 264(9):5128-33. PubMed ID: 2647747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure.
    Tollefsen DM; Pestka CA
    Blood; 1985 Oct; 66(4):769-74. PubMed ID: 4041618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin cofactor II modulates the response to vascular injury.
    Tollefsen DM
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):454-60. PubMed ID: 17194895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
    Maimone MM; Tollefsen DM
    J Biol Chem; 1990 Oct; 265(30):18263-71. PubMed ID: 2211700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of heparin cofactor II in the modulation of hemostasis.
    Salem HH; Thompson EA
    Dev Biol Stand; 1987; 67():67-72. PubMed ID: 3301469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II.
    He L; Giri TK; Vicente CP; Tollefsen DM
    Blood; 2008 Apr; 111(8):4118-25. PubMed ID: 18281504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.